Status:
COMPLETED
Effect of Botulinum Toxin to Hallux Valgus in Addition to Total Contact Insole
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Hallux Valgus
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The investigators propose a new therapeutic approach by injecting Botulinum Toxin Type A (BTA) to the oblique and transverse heads of adductor muscle of the great toe. BTA works by binding presynaptic...
Detailed Description
This is a randomized, double-blind, placebo-controlled prospective study to assess the influence and efficacy of intramuscular (IM) Botulinum Toxin Type A (BTA) injection in patients with painful hall...
Eligibility Criteria
Inclusion
- hallux valgus with angle of at least 20°,
- single or bilateral hallux valgus.
Exclusion
- history of foot operations,
- rheumatoid arthritis and gouty arthritis.
- Any contraindication on BTA administration
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01501500
Start Date
August 1 2010
End Date
August 1 2013
Last Update
September 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung MH
Guishan, Taoyuan, Taiwan, 333